Exhibit 061

Gates Foundation puts $52M behind CureVac

Exhibit 061 · Journalism

Gates Foundation puts $52M behind CureVac

The Gates Foundation made a $52 million equity investment in CureVac for its mRNA platform and a manufacturing facility, at the time the foundation's largest equity investment.

Source: FiercePharma
Date: March 2015
Grade: Reported
Document: https://www.fiercepharma.com/deals/gates-foundation-puts-52m-behind-curevac-following-sanofi-boehringer-s-lead
Accessed: 2026-11-09
Cited by: Findings citing this exhibit

Cited by

Finding MED-2.8: Primary record The Gates Foundation launched Gavi with a $750 million pledge in 2000 and has taken equity stakes in mRNA vaccine developers, including BioNTech in September 2019.